Neurological manifestations of postcovid syndrome

This article is in "Library" - "COVID-19" section.

Author:
P.R. KAMCHATNOV1, R.A. CHEREMIN2, L.A. SKIPETROVA2, A.V. CHUGUNOV1
1N.I. Pirogov Russian National Research Medical University, Moscow, Russia;
2Center of Speech Pathology and Neurorehabilitation, Moscow, Russia

Read more.


Study of the efficacy and safety of sequential use of the drugs Mexidol and Mexidol FORTE 250 in the treatment of stroke

This article is in "Library" - "Neurology" section.

Author:

S.M. KARPOV1, M.YU. MOROZOVA2, K.A. MURAVYOV2, I.A. VYSHLOVA1, F.S. KANTEMIROVA3

1Stavropol State Medical University, Stavropol, Russia;
2City Clinical Hospital No. 3, Stavropol, Russia;
3Georgievsky Medical Academy, Simferopol, Russia

Read more.


Generic drugs: benefit/risk ratio

This article is in "Library" section.

Author:
Ushkalova E.A.1, Zyryanov S.K.1,2, Gopienko I.A.1

1Peoples' Friendship University of Russia (RUDN University), Moscow;
2City Clinical Hospital Twenty-Four, Moscow Healthcare Department, Moscow, Russia

Read more.


Antioxidant activity and toxicity of ethylmethylhydroxypyridine succinate and edaravone: comparative in vitro experiment

This article is in "Library" section.

Author:
A.V. SHCHUL’KIN, YU.V. ABALENIKHINA, P.D. EROKHINA, AND E.N. YAKUSHEVA

Ryazan State Medical University, ul. Vysokovoltnaya 9, Ryazan, 390026 Russia

Read more.


Original and generic drugs: what does the clinician need to know?

This article is in "Library" section.

Author:

A.V. SHCHULKIN, A.A. FILIMONOVA

Ryazan State Medical University, Ryazan, Russia

Read more.


The efficacy and safety study of Mexidol and Mexidol FORTE 250 in patients with chronic cerebral ischemia

This article is in "Library" section.

Author:
L.A. SHCHEPANKEVICH1,2, YU.A. NIKOLAEV1, E.V. TANEEVA3, M.A. PERVUNINSKAYA1, M.S. SHCHEPANKEVICH1,2

1Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia;
2Novosibirsk State Medical University, Novosibirsk, Russia;
3State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russia

Read more.


Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)

This article is in "Library" section.

Author:

A.I. FEDIN1, V.V. ZAKHAROV2, M.M. TANASHYAN3, E.I. CHUKANOVA1, E.N. MADZHIDOVA4, L.A. SHCHEPANKEVICH5,6, O.D. OSTROUMOVA7

1Russian National Research Medical University named after N.I. Pirogov, Moscow, Russia;
2Sechenov First Moscow Medical University (Sechenov University), Moscow, Russia;
3Scientific Center of Neurology, Moscow, Russia;
4Tashkent Pediatric Medical Institute, Tashkent, Republic of Uzbekistan;
5Novosibirsk State Medical University, Novosibirsk, Russia;
6Federal Research Center for Fundamental and Translational Medicine, Novosibirsk, Russia;
7Russian Medical Academy of Continuous Professional Education, Moscow, Russia

Read more.


Vascular inflammation underlies the development of atherothrombotic stroke

This article is in "Library" section.

Author:

A.V. ROMANENKO, I.P. AMELINA, E.YU. SOLOVYEVA
Pirogov Russian National Research Medical University, Moscow, Russia

Read more.


Features of the patient management with traumatic brain injury

This article is in "Library" section.

Author:

M.L. CHUKHLOVINA1, A.A. CHUKHLOVIN2

1Almazov National Medical Research Center, Ministry of Healthcare, St. Petersburg, Russia

2Polenov Russian Research Neurosurgical Institute — Branch Almazov National Medical Research Center, St. Petersburg, Russia

Read more.


Treatment of alcohol withdrawal syndrome

This article is in "Library" section.

Author:

Y.P. SIVOLAP
Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

Read more.